Why Myriad Genetics (MYGN) Stock Is Trading Lower Today [Yahoo! Finance]
How Recent Developments Are Shaping the Myriad Genetics Investment Story [Yahoo! Finance]
Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health [Yahoo! Finance]
Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health
Myriad Genetics (NASDAQ:MYGN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.